Diabetic Markers, Five Years after Bariatric Surgery

Abstract

Background: Bariatric surgery delivers substantial weight loss for obese patients with comorbidities like diabetes mellitus. We aimed to investigate the impacts of bariatric surgery on diabetic markers after 5 years of follow-up. Methods: This is a retrospective study on patients with diabetes and a history of bariatric surgery between 2016-2017. The diabetic markers before and 5 years following surgery, including a lipid profile, glucose level, and the required antidiabetic medications, were evaluated. Results: 34 consecutive patients were included, 30 (88.2%) women, with a mean age of 52.71 ± 8.53 years. The majority (65%) of surgeries were Roux-en-Y gastric bypass (RYGB), and the remaining were one anastomosis gastric bypass (OAGB) and sleeve gastrectomy (SG). The serum levels of diabetic markers reduced during follow-up (P= 0.001), except for high-density lipoprotein levels and serum total cholesterol, which increased (P= 0.011, P= 0.838). Low-density lipoprotein levels reduced, but it was insignificant (P= 0.194). Surgery types had affected the changes of diabetic markers (P> 0.05). Demand for oral medication was reduced significantly, but insulin injection reduction was not significant (P= 0.006 and P= 0.099, respectively). Conclusion: Our study showed favorable bariatric surgery results on patients with diabetes in long-term follow-up. However, d sli idemia is still a concern